Prot #CXA-NP-11-04: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PHASE 3 STUDY TO ASSESS THE SAFETY AND EFFICACY OF INTRAVENOUS CEFTOLOZANE/TAZOBACTAM COMPARED WITH MEROPENEM IN ADULT PATIENTS WITH VENTILATED NOSOCOMIAL PNEUMONIA

Project: Research project

StatusActive
Effective start/end date11/11/145/31/20

Funding

  • INC Research, LLC (Prot #CXA-NP-11-04)
  • Cubist Pharmaceuticals, Inc. (Prot #CXA-NP-11-04)